ADCY1 and hyperthyroidism: Components such as the β1-adrenergic receptor and downstream effectors including adenylate cyclase are transcriptionally upregulated, explaining the efficacy of β-blockers in ameliorating both the hemodynamic and electrophysiological manifestations of hyperthyroidism [11].